Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series.

@article{Bienfang2000HydroxychloroquineRD,
  title={Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series.},
  author={Don C. Bienfang and Jonathan S. Coblyn and Matthew H. Liang and Michael Corzillius},
  journal={The Journal of rheumatology},
  year={2000},
  volume={27 11},
  pages={2703-6}
}
We describe a consecutive series of patients with hydroxychloroquine (HCQ) retinopathy. Their clinical features illustrate that with normal renal function there is no threshold for total dosage for HCQ toxicity; that color vision testing is important; that almost all patients complain of altered central vision as their first symptom; and that a normal optic fundus does not exclude the diagnosis. Finally, HCQ retinopathy may progress even when the agent is stopped.